S1PR-1/5 modulator RP-101074 shows beneficial effects in a model of central nervous system degeneration

IntroductionIn multiple sclerosis (MS), chronic disability primarily stems from axonal and neuronal degeneration, a condition resistant to conventional immunosuppressive or immunomodulatory treatments. Recent research has indicated that selective sphingosine-1-phosphate receptor S1PR-1 and -5 modula...

Deskribapen osoa

Xehetasun bibliografikoak
Egile Nagusiak: Mustafa Sindi, Christina Hecker, Andrea Issberner, Tobias Ruck, Sven G. Meuth, Philipp Albrecht, Michael Dietrich
Formatua: Artikulua
Hizkuntza:English
Argitaratua: Frontiers Media S.A. 2023-08-01
Saila:Frontiers in Immunology
Gaiak:
Sarrera elektronikoa:https://www.frontiersin.org/articles/10.3389/fimmu.2023.1234984/full